Print
Health Care

New Lab In Wisconsin Expands Wilmington Based PPD's Testing Capabilities

By Jenny Callison, posted Mar 29, 2018
PPD this week announced a new analytical laboratory at its existing facility in Middleton, Wisconsin. The lab will expand PPD’s testing capacity, according to an announcement Wednesday by the Wilmington-based company.

The 32,000-square-foot Good Manufacturing Practices (GMP) lab “supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products,” the news release stated.

Planned for a workforce of more than 100, the new lab contains specialized areas designed for particular types of assays and scientific instrumentation specific to biologics, according to the release.

Biological products, or biologics, include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues and recombinant therapeutic proteins.

According to the Federal Drug Administration, biologics – as distinguished from chemical synthetics – are products isolated from a variety of natural sources. 

“The expansion of our biologics testing, which nearly doubles our analytical testing capacity, enables us to meet the ever-growing needs of our clients for GMP testing of large molecule products,” Jon Denissen, senior vice president of the PPD Laboratories bioanalytical and GMP labs, said in the release. “From early clinical development through commercial release testing, clients rely on our industry-leading capabilities in large molecule product testing. With deep expertise that spans the full spectrum of protein-based and gene-based biologics, we support many of the most cutting-edge immuno-oncology, gene therapy and cell therapy agents being developed or marketed today.”

PPD is also renovating its existing cell lab at the Middleton campus to double the lab’s capacity for GMP cell-based assays, the release stated, adding, “The expanded 5,900-square-foot laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
Deedee gasch

An Injury is Reported at Your Business… Now What?

Deedee Gasch - Cranfill Sumner & Hartzog LLP
Jim ellis headshot 10311631058

Why Your Company Needs a Corporate Video

Jim Ellis - Signal
Leath 683x10242

Post-Flo Stress and Anxiety Management  

Lisa Leath - Leath HR Group

Trending News

The Last Of The Offices At Mayfaire Sells For $11.7M

Cece Nunn - Feb 12, 2019

Coming To Downtown Wilmington: Mellow Mushroom

Cece Nunn - Feb 12, 2019

A First Look At The Next Phase Of Autumn Hall

Cece Nunn - Feb 14, 2019

ILM Awards Contract For Second Phase Of Terminal Expansion

Christina Haley O'Neal - Feb 13, 2019

Smith + Gsell Design Firm Develops Studio Space, Residential Homes

Johanna Cano - Feb 13, 2019

In The Current Issue

Changing Tides

While some might expect the growth spurt in the town of Carolina Beach to cause major growing pains, town officials say the challenges posed...


Housing Market: When History's For Sale

Homebuyers in the market for a historical dwelling seem to have at least one thing in common: a love of storied structures, big or small....


Pushing Investment Crowdfunding

After almost two years since the NC PACES Act was enacted, three companies have completed crowdfunding fillings with the state, demonstratin...

Book On Business

The 2019 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Health Care Heroes 2018
2018 WilmingtonBiz Expo - Keynote Lunch with Eric Dinenberg, Rouse Properties